|
Volumn 11, Issue 4, 2004, Pages 343-
|
Orthopaedics: Gene therapy's dark horse
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
COMPLEMENTARY DNA;
GENE PRODUCT;
GROWTH FACTOR;
ANTERIOR CRUCIATE LIGAMENT;
ARTHRITIS;
ARTHROPATHY;
BONE DISEASE;
BONE TUMOR;
CARTILAGE;
CHRONIC DISEASE;
CLINICAL PRACTICE;
EDITORIAL;
GENE EXPRESSION;
GENE MUTATION;
GENE TARGETING;
GENE TECHNOLOGY;
GENE THERAPY;
GENE TRANSFER;
GENETIC DISORDER;
HEALING;
HUMAN;
INTERVERTEBRAL DISK;
JOINT PROSTHESIS;
NONHUMAN;
ORTHOPEDICS;
OSTEOGENESIS IMPERFECTA;
OSTEOLYSIS;
OSTEOPOROSIS;
PRIORITY JOURNAL;
PROSTHESIS LOOSENING;
SYNOVIUM;
TISSUE REGENERATION;
TISSUE REPAIR;
TRANSGENE;
GENE THERAPY;
HUMANS;
MUSCULOSKELETAL DISEASES;
ORTHOPEDIC PROCEDURES;
ADENOVIRIDAE;
EQUUS CABALLUS;
|
EID: 1342285056
PISSN: 09697128
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.gt.3302212 Document Type: Editorial |
Times cited : (10)
|
References (0)
|